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ABSTRACT
Objective: The aspiration of the current research involves employing various concentrations of polymer and filler to develop indomethacin sustained 
release (SR) matrix tablets. The objective of this research work is to reduce dosing frequency thereby increasing patients compliance and enhanced 
therapeutic activity.
Methods: Polymers such as Almond gum (AG), polyvinylpyrrolidone (PVP), and starch at different concentrations were used for formulating SR 
polymeric matrix tablets. Evaluation of pre-compression and post-compression parameters was done for both granules and formulated tablets.
Results: Results obtained from pre-compression parameters and post-compression parameters suggested that all the parameters are within the 
prescribed limits, demonstrating that formulated granules had shown better flow properties. The morphological characteristics of the developed 
tablet were observed by employing scanning electron microscope where the surface of the tablet was found to be smooth from the in vitro dissolution 
study, combination of AG (30 mg) with PVP (30 mg), and starch used as a filler has sustained the release of drug up to 10 h.
Conclusion: Therefore, developed polymeric matrix tablet exhibited enhanced potency over a conventional tablet by exhibiting an excellent 
dissolution profile for a period of 10 h.
Keywords: Almond gum, Indomethacin, Starch, Matrix tablet, Sustained release, Polyvinylpyrrolidone.
INTRODUCTION
In recent times, the introduction of tablets as sustained release 
(SR) dosage forms has bought a transformation in pharmaceutical 
technology. Where the drug was sustained for a prolonged duration of 
time in the systemic circulation by incorporating in polymeric matrices 
that have a short-term elimination half-life by releasing the drug in 
a zero-order pattern and developed as a SR dosage forms [1]. These 
dosage forms offer a number of benefits over an immediate release 
dosage forms, such as better patient acceptance due to reduce dosing 
frequency, portability, convenience, negligible side effects and shows 
enhanced pharmacological and therapeutic effects. The polymers 
which are widely employed in SR matrices are hydrophilic polymers 
(cellulosic and non-cellulosic) or hydrophobic polymers (ethyl-
cellulose, hypromellose acetate succinate, cellulose acetate propionate, 
polyvinyl acetate, etc.) [2].
In recent times among other strategies matrix tablets are gaining 
importance due to its release pattern of the drug, convenient method of 
formulation, ease of processing, and lesser cost of production. Loading 
of drug into the polymer matrix can be done by coating or as a bi-layer, 
either granulation or direct compression can be used to formulate 
matrix tablet. To choose the appropriate method to formulate matrix 
tablets rely on the nature of the API and other excipients [3].
Indomethacin (IM) is an nonsteroidal anti-inflammatory drug usually 
adopted to diminish fever, pain, stiffness in rheumatic disease, and 
swelling from inflammation. IM inhibits the prostaglandin production; 
endogenous signaling molecules present these symptoms which were 
exhibited by inhibiting cyclooxygenase, enzyme that catalyzes the 
production of prostaglandins [4].
MATERIALS AND METHODS
Materials
IM was purchased from Yarrow Chem product, Mumbai, India; Almond 
gum &(AG) was obtained from a local certified ayurvedic market and 
exudates; polyvinylpyrrolidone (PVP-30) SRL, Mumbai India; Starch, 
Taclum, and Mg-Stearate were obtained from Loba, and Isopropyl 
alcohol was obtained from Merck Mumbai.
Experimental methods
Preformulation studies
Pre-formulation studies can be termed as the examination of 
physicochemical characteristics of a drug substance alone. The 
main reason to perform these studies is to acquire bioavailable and 
unchanging dosage forms by providing useful information to the 
formulator.
Development of prolonged release formulation of IM
Wet granulation technique was adopted for formulating the SR matrix 
tablets. In the current work, SR tablets were formulated by employing 
varied concentrations of AG along with binder (PVP K30). As shown in 
Table 1, six preparations of IM were formulated. Ingredients mentioned 
in Table 1 were weighed, sieved, and finally blended. The obtained 
blend was then sieved, dried, and compressed [5].
Micromeritic properties
The physical properties of the powder were analyzed for flowability. 
Carr’s index equation was employed to determine the flow property of the 
powder blend. In this method, using a Scoopula and the mass occupied by 
the powder was recorded using a 100ml measuring cylinder. Using, well-
established formula, that is, weight divided by the volume of the blend, 
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the bulk density of mixture was measured. Mixture was then allowed to 
settle by tapping it for a count of 100 times using different cylinders. To 
measure the tapped density, the process was continued until a constant 
value was attained. Angle of repose was the most widely used technique 
for measuring the flowability [by determining the shape of the powder 
heap]. The formula used to measure the flowability [6].
Tanθ = h/r
Tablet compression
The talc and mg-stearate were used separately for lubricating the dried 
granules. Per each tablet, 50 mg of IM equivalent SR granules were 
weighed, and tablets were compressed using a 10 station lab compressor.
Physical properties of SR tablets
Weight variation
Initially, 20 units were selected randomly which were then weighed 
individually, and the average was calculated. In comparison with the 
percentage given in the pharmacopeia, deviation for any two tablets 
should not be more than the average weight. Weight variation was 
carried out using digital balance [7,8].
Tablet thickness
In this, 10 tablets were assessed for thickness using electronic Vernier 
caliper, Mitutoyo, Japan [7,8].
Hardness
Hardness is defined as the resistance of a material to permanent 
deformation such as indentation, wear, abrasion, and scratch. Monsanto 
tester was employed for evaluating the hardness of 10 tablets. The two 
main processes to test the hardness of the tablet: Compression testing 
and three-point bends testing. The hardness of oral tablets usually 
varies from 4 to 8 or 10 kg/cm² [9].
Friability
Roche friabilator or tumbler test was used for measuring the friability. 
Friabilator implies the ability of the compressed tablet to deter fracture 
and breakage during shipping. Friability is illustrated as the percentage 
of weight reduction due to mechanical action during the test. Tablets 
were weighed before and after testing and friability can be recorded as 
a percentage loss on pre-test tablet weight. 10 tablets were evaluated 
by Roche type friability test apparatus at the rate of 25 rpm for 4 min. 
The weight difference due to abrasion is the measure of tablet friability; 
the value is expressed in terms of percentage, minimum weight loss of 
the compressed tablet should be NMT 1% [9,10].
Drug content
Crushed powder of 20 tablets of the SR formulations was weighed. 
Powder equivalent to 200 mg of IM was taken in a 100 mL volumetric flask 
containing pH-7.2 phosphate buffer. Absorbance was measured at 265 nm 
for the diluted and filtered solutions to estimate the drug content [11,12].
Surface topography of matrix tablet by scanning electron 
microscope (SEM)
The surface texture of the developed formulations can be investigated 
using the SEM Hitachi Noran System 7 manufactured by Thermo Fisher 
Scientific technique. The surface texture of the formulated bi-layer matrix 
tablet can be determined by employing the SEM technique [13,14].
Dissolution study
Electrolab USP dissolution testing apparatus II (paddle type) was used 
to evaluate the rate of drug release from matrix tablets. Initially, test was 
carried out using 750 mL of 0.5N HCL (pH 1.2) for 2 h at 37±0.5°C to which 
250 mL of 0.2N phosphate buffer was added, and pH was adjusted to 6.8 
for the remaining period of duration (8 h); thus, the test was carried out 
for time period of 10 h at 37±0.5°C. A sample of 10 mL was withdrawn 
at regular intervals, was then supplanted with the same volume of fresh 
pre-warmed dissolution medium. Withdrawn sample was filtered and 
analyzed spectrophotometrically at wavelength 265 nm [15,16].
RESULTS AND DISCUSSION
Micromeritic properties of granules
As described earlier matrix dosage forms were prepared using wet 
granulation method. Granulation is the key step in the formulation of 
SR matrix tablet. The properties of the granules were assessed and 
depicted in Table 2.
Table 1: Composition of IM formulations with different AG 
concentrations along with starch as filler
Composition Formulation
F1 F2 F3 F4 F5 F6
IM (mg) 50 50 50 50 50 50
AG (mg) 15 20 25 30 35 40
PVP K30 (mg) 0 30 0 30 0 30
Starch (mg) 125 90 115 80 105 70
Talcum (mg) 5 5 5 5 5 5
Magnesium stearate (mg) 5 5 5 5 5 5
IPA (mL) 1 1 1 1 1 1
Total (mg) 200 200 200 200 200 200
IM: Indomethacin, AG: Almond gum, PVP: Polyvinylpyrrolidone











F1 24.02±0.05 0.41±01 0.551±0.05 15.01±0.21
F2 25.01±0.03 0.446±03 0.531±0.03 15.08±0.13
F3 24.21±0.14 0.413±0.2 0.502±0.09 12.07±0.17
F4 24.13±0.09 0.458±0.09 0.518±0.02 11.09±0.23
F5 24.01±0.04 0.436±0.08 0.508±0.04 14.02±0.26
F6 24.23±0.05 0.414±0.05 0.519±0.01 12.09±0.17
Table 3: Physical properties of the tablet
Formulation code Weight variation Hardness Thickness Friability Drug content
F1 201±2.26 5.2±0.12 4.5±0.15 0.48±0.12 98.03±0.12
F2 199±2.37 4.3±0.04 4.4±0.12 0.53±0.12 97.09±0.12
F3 199±3.42 5.2±0.03 4.6±0.08 0.41±0.02 97.07±0.03
F4 200±1.06 5.3±0.08 4.4±0.16 0.43±0.05 98.03±0.12
F5 201±1.06 4.3±0.06 4.4±0.09 0.61±0.11 97.09±0.12
F6 199±0.77 4.3±0.12 4.6±0.28 0.55±0.04 94.03±0.12
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Bulk density
The bulk density values ranged from 0.41±01 to 0.458±0.09 (Table 2) 
suggesting that the obtained results were within the prescribed limits.
Tapped density
The values for the tapped density were within the range of 0.502±0.09–
0.551±0.05 (Table 2) assuring the free flow of granules.
Angle of repose
The results were ranged between 24.01±0.04 and 25.01±0.03 (Table 2) 
that is <30° which assures excellent flow properties of the powder.
Compressibility index
The values obtained were found to fall in the range of 11.09±0.23–
15.08±0.13 (Table 2). These observations suggested that the granules 
of all batches have showed good flow characters, and hence, were 
suitable for compression into matrix tablets.
Physical properties of matrix tablet
Formulated SR tablets of IM were analyzed for post-compression 
parameters such as weight variation, thickness, hardness, friability, and 
drug content. The results were depicted in Table 3. From the results, 
it was evident that values from all the tests were within the limits 
prescribed by pharmacopeia.
Weight variation
The results from the weight variation varied from 199±0.77 to 201±2.26 
and were found to be within the pharmacopeial specifications that is 
±7.5% (Table 3).
Tablet thickness
The formulated sustained matrix tablets loaded with IM had showed 
thickness varying from 4.4±0.09 to 4.6±0.28 (Table 3), and the average 
value of thickness was found to be within the range ±5% as prescribed 
by pharmacopeia.
Hardness
The variation in hardness of the formulated sustained matrix tablets 
loaded with IM was in the range of 4.3±0.04–5.3±0.08 kg (Table 3), 
suggesting acceptable mechanical strength with a capability to endure 
mechanical and physical stress circumstances while handling and 
shipping.
Friability
Decrease in the weight of the sustained matrix formulations due to 
friability was observed to be in the range of 0.41±0.02%–0.55±0.04% 
(Table 3), results suggested that formulated tablets were mechanically 
stable.
Drug content
Drug content values obtained from various formulations were highly 
uniform and within the range of 94.03±0.12–98.03±0.12 (Table 3). The 
maximum percentage drug content among various formulations was 
found to be 98.03±0.12%. The minimum percentage of drug content 
was found to be 94.03±0.12% for all the batches. All the values of the 
drug content were within limits specified by pharmacopeia.
Surface topography of matrix tablet by SEM
By employing SEM, the surface morphology of SR layer of matrix tablet 
was determined. From, Fig. 1 SEM photographs exhibit the intact SR layer 
of IM after 1 h, 4 h, and 8 h of dissolution study. SEM photomicrograph 
taken at different time intervals of sustained matrix tablet after the 
dissolution study presented that the matrix was unimpaired and the 
matrix had pores throughout its surface. Tablet surface also exhibited 
erosion of matrix has proportionately enhanced with reference to 
time as indicated by the photocopies at 2, 4, and 8 h and explaining 
that there is an increase in the diameter of the pores. The formation of 
gelling structure was explained by these photomicrographs revealing 
the probability of swelling of the formulated dosage form (Fig. 1). The 
release of IM from developed formulation was due to the formation 
of the pores and gelling structures (due to diffusion and erosion 
mechanism) on the tablet surface.
Dissolution study
Dissolution of the formulated IM SR matrix tablets takes place by 
swelling between the polymer networks by which the drug is getting 
diffused into the dissolution medium. Thus, the release of the active 
agent from the matrix tablet takes place by the diffusion mechanism. As 
shown in Fig. 2, formulation F4 had shown the accurate and complete 
release of the drug by 10 h. From the results, it can be inferred that 
formulation F4 can be considered as optimized formulation as it had SR 
of IM up to 10 h [14].
CONCLUSION
Matrix tablets loaded with IM was formulated using wet granulation 
method to sustain the release of drug for a period of time. The pre-
compressional (micromeritics properties) and the post-compressional 
parameters (physical properties) were found to be within the 
pharmacopeial limits. From the various formulations F4 with 30 mg 
Fig. 1: Surface of sustained release layer of indomethacin (a) after 1 h, (b) after 4 h, and (c) after 8 h of dissolution investigated by SEM
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of almond gm, 30 mg of PVP and 80 mg of starch were considered as 
optimized formulation based on its drug release pattern, i.e., 10 h, 
which was better when compared with other formulations. SEM 
photographs of F4 suggested that tablet surface exhibited erosion of 
matrix with reference to the time at 2, 4, and 8 h, which explains the 
increase in diameter of the pores and facilitates the drug release from 
the uniform surface of the matrix tablet. Therefore, it can be concluded 
that IM matrix tablets can be used for enhancing both the therapeutic 
efficacy and patient acceptance by reducing the dosing intervals.
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